Page 276 - 2021_04-Haematologica-web

1192
Letters to the Editor
County Medical Center. NRD. and MTZ performed in silico protein modeling. LSR, KAR, FPL, MMP and AS wrote the manuscript with input from the other authors.
Acknowledgments: we thank the proband for participating in this study.
Funding: this work was supported in part by the Mayo Clinic Center for Individualized Medicine and the “Henry Predolin Leukemia Foundation” and by a Starr Cancer Consortium grant (to AS), National Institutes of Health (NIH) RO1 HL120922 (to AS), and grant # UL1TR001866 from the National Center for Advancing Translational Sciences, NIH Clinical and Translational Science Award program. KAR was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH under award number T32GM007739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program. AS is a Howard Hughes Medical Institute.Faculty Scholar. The content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
References
1.Fiesco-Roa MO, Giri N, McReynolds LJ, Best AF, Alter BP. Genotype-phenotype associations in Fanconi anemia: a literature review. Blood Rev. 2019;37:100589.
2. Kottemann MC, Smogorzewska A. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature. 2013;493(7432):356- 363.
3. Niraj J, Farkkila A, D'Andrea AD. The Fanconi anemia pathway in cancer. Annu Rev Cancer Biol. 2019;3:457-478.
4. Meetei AR, de Winter JP, Medhurst AL, et al. A novel ubiquitin lig- ase is deficient in Fanconi anemia. Nat Genet. 2003;35(2):165-170.
5. Machida YJ, Machida Y, Chen Y, et al. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell. 2006;23(4):589-596.
6. Rickman KA, Lach FP, Abhyankar A, et al. Deficiency of UBE2T, the E2 ubiquitin ligase necessary for FANCD2 and FANCI ubiquitina- tion, causes FA-T subtype of Fanconi anemia. Cell Rep. 2015;12(1):35-41.
7. Hira A, Yoshida K, Sato K, et al. Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia. Am J Hum Genet. 2015;96(6):1001-1007.
8. Virts EL, Jankowska A, Mackay C, et al. AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia. Hum Mol Genet. 2015;24(18):5093-5108.
9. Mangaonkar AA, Ferrer A, Pinto EVF, et al. Clinical applications and utility of a precision medicine approach for patients with unex- plained cytopenias. Mayo Clin Proc. 2019;94(9):1753-1768.
10. Hodson C, Purkiss A, Miles JA, Walden H. Structure of the human FANCL RING-Ube2T complex reveals determinants of cognate E3- E2 selection. Structure. 2014;22(2):337-344.
11. Kelsall IR, Langenick J, MacKay C, Patel KJ, Alpi AF. The Fanconi anaemia components UBE2T and FANCM are functionally linked to nucleotide excision repair. PLoS One. 2012;7(5):e36970.
12. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommenda- tion of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424.
13. Lv Z, Rickman KA, Yuan L, et al. S. pombe Uba1-Ubc15 structure reveals a novel regulatory mechanism of ubiquitin E2 activity. Mol Cell. 2017;65(4):699-714.e6.
14. Hira A, Yabe H, Yoshida K, et al. Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. Blood. 2013;122(18):3206-3209.
haematologica | 2021; 106(4)